--- title: Buy Generic Imiquimod 5% Topical Cream Tube description: Imiquimod 5% cream treats genital warts and certain skin conditions. Order this effective topical treatment from our secure online pharmacy with reliable delivery. type: product language: en url: https://liabilis.com/order-imiquimod-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 52.24 price_max: 407.54 currency: USD offers: - name: 5% x 3 tubes price: 52.24 - name: 5% x 6 tubes price: 99.74 - name: 5% x 9 tubes price: 148.99 - name: 5% x 12 tubes price: 177.64 - name: 5% x 15 tubes price: 208.99 - name: 5% x 18 tubes price: 247.99 - name: 5% x 24 tubes price: 292.59 - name: 5% x 36 tubes price: 407.54 --- # Buy Generic Imiquimod 5% Topical Cream Tube Imiquimod is an immune response modifier cream that stimulates the body's immune system to fight certain skin conditions. It is primarily used to treat external genital warts and actinic keratosis, helping the body eliminate abnormal skin cells and lesions. This topical treatment is designed for adults seeking FDA-approved solutions for these specific dermatological concerns. Our pharmacy offers the 5% strength imiquimod in convenient tube packaging for easy application. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **5%** | 3 tubes | **$52.24** | $17.41 | In Stock | | **5%** | 6 tubes | **$99.74** | $16.62 | In Stock | | **5%** | 9 tubes | **$148.99** | $16.55 | In Stock | | **5%** | 12 tubes | **$177.64** | $14.80 | In Stock | | **5%** | 15 tubes | **$208.99** | $13.94 | In Stock | | **5%** | 18 tubes | **$247.99** | $13.78 | In Stock | | **5%** | 24 tubes | **$292.59** | $12.19 | In Stock | | **5%** | 36 tubes | **$407.54** | $11.32 | In Stock | [Buy Now](https://liabilis.com/order-imiquimod-online-en.html) ## Introduction Imiquimod is a synthetic immune response modifier applied topically to treat certain skin lesions. The active ingredient is imiquimod, supplied in a tube as a 5 % cream. It belongs to the class of immune-modulating agents that stimulate local antiviral and antitumor activity. Approved indications include actinic keratosis, superficial basal cell carcinoma, and external genital warts. Patients may also encounter it for investigational uses under medical supervision. ## Quick Reference Facts ``` **Active Ingredient** : Imiquimod **Form** : tube 5 % cream **Primary Uses** : - Actinic keratosis - Superficial basal cell carcinoma - External genital warts (condyloma acuminata) ``` ## What is Imiquimod? Imiquimod is the generic version of medications containing the active compound imiquimod. It is marketed under several brand names, most notably **Aldara®** (5 % cream) and **Zyclara®** (3 % cream). The 5 % formulation is the most widely prescribed for the approved skin conditions listed above. Development began in the 198s, and the U.S. Food and Drug Administration (FDA) approved the 5 % cream for actinic keratosis in 1997, later expanding indications to basal cell carcinoma and genital warts. The product is manufactured by various licensed pharmaceutical companies that meet international GMP standards. ## How Imiquimod Works Imiquimod binds to Toll-like receptor 7 (TLR-7) on plasmacytoid dendritic cells and other antigen-presenting cells in the skin. This interaction triggers a cascade that releases cytokines such as interferon-α, tumor necrosis factor-α, and interleukins 6, 8, and 12. The resulting immune milieu enhances antiviral defenses and promotes apoptosis of dysplastic keratinocytes. Because the effect is localized to the site of application, systemic exposure is minimal, allowing the drug to act directly where the lesion resides while preserving overall immune balance. ## Conditions Treated with Imiquimod - **Actinic keratosis** Chronic sun-induced precancerous lesions are cleared as imiquimod-induced immune activity destroys atypical keratinocytes, reducing the risk of progression to squamous cell carcinoma. - **Superficial basal cell carcinoma (sBCC)** Imiquimod creates a localized inflammatory response that eradicates malignant basal cells confined to the epidermis and superficial dermis, offering a non-surgical alternative for select lesions. - **External genital warts (condyloma acuminata)** Human papillomavirus-driven warts regress when imiquimod stimulates antiviral cytokines, leading to lesion disappearance without the need for destructive procedures. ## Is Imiquimod the Right Medication for You? Imiquimod is most suitable for adults with confirmed diagnoses of the approved conditions who prefer or require a topical approach. It is especially considered when surgery is contraindicated, cosmetically undesirable, or when lesions are numerous and diffusely distributed. Patients with a known hypersensitivity to imiquimod or any excipients in the cream should avoid it. Immunosuppressed individuals (e.g., organ-transplant recipients, those on systemic steroids) may experience reduced efficacy and a higher incidence of severe local reactions; careful risk-benefit assessment is essential. Pregnant or nursing women should only use imiquimod if the potential benefit outweighs possible risks, as safety data are limited. ## Buying Imiquimod from [our online pharmacy](https://liabilis.com/order-imiquimod-online-en.html) ### Why Choose Our Service? Accessing topical therapies can be challenging due to insurance restrictions or limited pharmacy stock. Our platform connects you with a trusted source of generic imiquimod you receive the medication you need without unnecessary delays or cost barriers. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every shipment undergoes verification against regulatory standards, guaranteeing that the 5 % cream you receive meets the specifications required for safe topical use. ### Pricing & Access Because this is the generic formulation, the price is substantially lower than brand-name alternatives such as Aldara® while providing identical therapeutic potency. Our competitive pricing helps patients obtain the medication at near-manufacturer cost, easing financial concerns that often accompany long-term skin-condition management. ### Discreet Delivery Orders are packaged in unmarked, tamper-evident envelopes and dispatched via express delivery typically within 7 days, or standard airmail in approximately 3 weeks. This ensures privacy and convenience for patients who value confidentiality. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** (per FDA labeling): - *Actinic keratosis*: Apply a thin layer once daily, five nights per week for 4 weeks. - *Superficial basal cell carcinoma*: Apply once daily, five nights per week for 6 weeks. - *Genital warts*: Apply once daily, five nights per week for up to 16 weeks or until lesions resolve. - **Missed dose**: Apply the missed dose the following night if there is at least an 8-hour gap from the previous application. Do not apply two doses on the same night. - **Overdose**: Excessive application may cause severe local irritation, ulceration, or systemic flu-like symptoms. If an overdose is suspected, wash the area with mild soap and water, discontinue use, and seek medical attention promptly. - **Precautions**: - Apply to clean, dry skin; avoid contact with eyes, mouth, or mucous membranes. - Do not cover the treated area with occlusive dressings unless instructed. - Alcohol and other skin irritants can exacerbate local reactions; avoid using additional topical products on the same site. - Operating heavy machinery is not restricted, but intense local inflammation may limit comfort. ## Safety Information ### ⚠️ Who Should Not Take Imiquimod - Known hypersensitivity to imiquimod or any component of the cream. - Patients with active autoimmune disorders involving the skin (e.g., lupus erythematosus) where heightened immune activation may worsen disease. - Individuals with severe immunodeficiency where a robust local immune response cannot be safely mounted. ### Common Side Effects - **Local skin reactions** - erythema, itching, burning, crusting, or swelling (most frequent, generally mild to moderate). - **Transient flu-like symptoms** - headache, mild fever, or fatigue, occurring in ≤10 % of users. - Management includes cooling the area with a wet compress, using gentle moisturizers, and limiting application time if irritation becomes pronounced. ### Serious Side Effects (Seek Immediate Medical Help) - Severe ulceration or necrosis of the treated skin. - Signs of systemic infection: high fever, chills, or spreading redness beyond the application site. - Allergic reactions such as angioedema, throat tightness, or anaphylaxis. If any of these occur, stop the medication and obtain urgent medical evaluation. ### Drug & Food Interactions - **Topical co-applications** - Concurrent use of other irritating topicals (e.g., retinoids, corticosteroids) may intensify local inflammation; stagger applications by at least 4 hours if combined therapy is unavoidable. - **Systemic immunomodulators** - Agents such as cyclosporine or biologic therapies can alter the immune response to imiquimod; coordinate with a healthcare provider before concurrent use. - No clinically significant dietary interactions have been reported. ## Off-Label and Investigational Uses of Imiquimod - **Molluscum contagiosum** - Small case series and pilot trials suggest lesion clearance with imiquimod, though results are inconsistent and not approved by regulatory agencies. - **Lentigo maligna (melanoma in situ)** - Early-phase studies indicate potential benefit when combined with excision, but definitive efficacy data are lacking. - **Viral warts on non-genital sites** - Some clinicians apply imiquimod to common warts; the evidence remains limited. All off-label applications should be undertaken only under the direct supervision of a qualified healthcare professional, with informed consent regarding the unapproved nature of the use. ## Storage & Handling - Store the tube at controlled room temperature (20-25 °C / 68-77 °F). - Protect from excessive heat, moisture, and direct sunlight. - Keep the container tightly closed when not in use. - Do not freeze. - Dispose of any remaining product according to local regulations; a pharmacy take-back program is recommended when available. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I apply Imiquimod while traveling internationally?** Yes, the cream can be taken abroad, but keep it in its original packaging, store it at room temperature, and be aware of any import restrictions imposed by the destination country. - **Will swimming affect the effectiveness of Imiquimod?** Water can wash away the medication. It is advisable to avoid submerging the treated area for at least 2 hours after application and to gently pat the skin dry afterwards. - **Is it safe to use sunscreen on treated skin?** Once the cream has been fully absorbed (approximately 30 minutes), a broad-spectrum sunscreen can be applied to protect against UV-induced damage without interfering with the drug’s activity. **Product & Formulation Details** - **What does the Imiquimod tube look like?** The product is supplied in a white, opaque tube containing a smooth, white to off-white cream. The label lists “Imiquimod 5 %” and includes batch number, expiration date, and storage instructions. - **Are there any inactive ingredients that might cause irritation?** The formulation contains petroleum jelly, mineral oil, and a small amount of dimethyl ether as a solvent. Patients with known sensitivities to these excipients should discuss alternatives with their provider. **Regulatory & Safety Nuances** - **Can Imiquimod be used during pregnancy?** Animal studies have shown adverse developmental effects, and human data are insufficient. The medication is classified as Pregnancy Category C; it should be prescribed during pregnancy only if the potential benefit justifies the potential risk. - **Will Imiquimod appear on a drug test?** Imiquimod is a topical agent and is not screened for in standard occupational drug-testing panels. - **Are there age restrictions for Imiquimod?** FDA approval is limited to adults (≥18 years) for the 5 % formulation. Use in younger patients requires special consideration and is generally off-label. **Scientific & Clinical Curiosity** - **What were the key trials that led to FDA approval?** Pivotal Phase III studies demonstrated ≥80 % complete clearance of actinic keratosis lesions after a 4-week regimen, with a safety profile comparable to other topical agents. - **How does Imiquimod compare with surgical excision for sBCC?** Randomized studies show similar cure rates for small, superficial lesions, while offering the advantage of tissue preservation and no scarring. - **Is there a risk of developing resistance to Imiquimod?** Because the drug works by stimulating the host immune response rather than targeting a viral or cellular protein directly, resistance is not a recognized clinical issue. ## Glossary **Toll-like receptor 7 (TLR-7)** : A pattern-recognition receptor on immune cells that detects single-stranded RNA motifs, triggering cytokine release when activated by agents like imiquimod. **Cytokine** : Small proteins released by immune cells that regulate inflammation and cellular communication; key mediators in imiquimod’s therapeutic effect. **Superficial basal cell carcinoma (sBCC)** : A subtype of basal cell skin cancer confined to the epidermis and superficial dermis, amenable to topical therapies. **Contraindication** : A specific situation or condition in which a drug should not be used because the risk outweighs any possible benefit. **Off-label use** : Application of a medication for an indication, dosage, or patient population that has not received formal regulatory approval. ## Disclaimer The information provided about **Imiquimod** is intended for general educational purposes and does not substitute a professional medical evaluation. All therapeutic decisions, including those concerning off-label applications, must be made under the guidance of a qualified healthcare professional. Readers are presumed to be competent adults capable of making informed health choices. Our pharmacy service offers access to generic Imiquimod for individuals who may encounter limited availability through conventional channels or who are seeking cost-effective options. Prior to initiating, modifying, or stopping any medication, consult your physician or pharmacist.